• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Liminatus Pharma, Inc. - Class A Common Stock (NQ:LIMN)

5.090 -0.840 (-14.17%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 837,709
Open 6.020
Bid (Size) 5.110 (1)
Ask (Size) 5.430 (10)
Prev. Close 5.930
Today's Range 4.200 - 6.308
52wk Range 4.200 - 33.66
Shares Outstanding N/A
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Liminatus Pharma Inc. to Launch “American BNB Strategy” Subsidiary and Target Up To $500 Million Fund for BNB Investment as Part of Crypto Market Initiative
July 28, 2025
Liminatus Identifies BNB Coin as Its Primary Strategic Target for Digital Asset Allocation, with Plans to Aggressively Accumulate and Hold Up to $500 Million for Long-Term Strategic Value 
From Liminatus Pharma Inc.
Via GlobeNewswire
Liminatus Pharma Inc. Evaluates Formation of Digital Asset Investment Vehicle Targeting Up To $500 Million in Capital Strategies
July 25, 2025
Strategic Internal Review initiated for treasury diversification through a prospective digital asset subsidiary — no entity formed, no capital committed 
From Liminatus Pharma Inc.
Via GlobeNewswire

Performance

YTD
-49.5%
-49.5%
1 Month
-26.6%
-26.6%
3 Month
-29.3%
-29.3%
6 Month
-49.5%
-49.5%
1 Year
-49.5%
-49.5%

More News

Read More
12 Health Care Stocks Moving In Thursday's Intraday Session
July 24, 2025
Via Benzinga
Liminatus Pharma Inc. Takes Next Step in Evaluating Digital Asset-Linked Capital Strategy
July 24, 2025
From Liminatus Pharma Inc.
Via GlobeNewswire
Get insights into the top gainers and losers of Thursday's pre-market session.
July 24, 2025
Via Chartmill
12 Health Care Stocks Moving In Thursday's Pre-Market Session
July 24, 2025
Via Benzinga
Liminatus Pharma, Inc. Initiates Strategic Review of Blockchain-Integrated Treasury Strategy
July 22, 2025
From Liminatus Pharma Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
July 17, 2025
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
July 10, 2025
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
July 09, 2025
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
July 03, 2025
Via Benzinga
US Stocks Likely To Open Higher: S&P 500 Sees 'Average Gain Of 6.1%' In 2nd Half, Expert Says
July 02, 2025
Via Benzinga
Topics Stocks
12 Health Care Stocks Moving In Monday's Pre-Market Session
June 30, 2025
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
June 27, 2025
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
June 26, 2025
Via Benzinga
AeroVironment Posts Better-Than-Expected Earnings, Joins QuantumScape, Bumble, BlackBerry And Other Big Stocks Moving Higher On Wednesday
June 25, 2025
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
June 25, 2025
Via Benzinga
Why BlackBerry Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
June 25, 2025
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
June 24, 2025
Via Benzinga
Carnival Posts Better-Than-Expected Earnings, Joins Liminatus Pharma, Coinbase Global, Uber And Other Big Stocks Moving Higher On Tuesday
June 24, 2025
Via Benzinga
Why Nektar Therapeutics Shares Are Trading Higher By Over 30%; Here Are 20 Stocks Moving Premarket
June 24, 2025
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
June 23, 2025
Via Benzinga
Kroger Posts Better-Than-Expected Earnings, Joins Couchbase, CarMax And Other Big Stocks Moving Higher On Friday
June 20, 2025
Via Benzinga
Why Beyond Air Shares Are Trading Lower By Over 23%; Here Are 20 Stocks Moving Premarket
June 18, 2025
Via Benzinga
Why Lennar Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
June 17, 2025
Via Benzinga

Frequently Asked Questions

Is Liminatus Pharma, Inc. - Class A Common Stock publicly traded?
Yes, Liminatus Pharma, Inc. - Class A Common Stock is publicly traded.
What exchange does Liminatus Pharma, Inc. - Class A Common Stock trade on?
Liminatus Pharma, Inc. - Class A Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Liminatus Pharma, Inc. - Class A Common Stock?
The ticker symbol for Liminatus Pharma, Inc. - Class A Common Stock is LIMN on the Nasdaq Stock Market
What is the current price of Liminatus Pharma, Inc. - Class A Common Stock?
The current price of Liminatus Pharma, Inc. - Class A Common Stock is 5.090
When was Liminatus Pharma, Inc. - Class A Common Stock last traded?
The last trade of Liminatus Pharma, Inc. - Class A Common Stock was at 08/04/25 04:00 PM ET
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap